Found: 6
Select item for more details and to access through your institution.
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 93, doi. 10.3390/cancers15010093
- By:
- Publication type:
- Article
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071372
- By:
- Publication type:
- Article
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines.
- Published in:
- Oncology Reports, 2023, v. 50, n. 3, p. N.PAG, doi. 10.3892/or.2023.8603
- By:
- Publication type:
- Article
Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma.
- Published in:
- Oncology Reports, 2023, v. 49, n. 6, p. N.PAG, doi. 10.3892/or.2023.8562
- By:
- Publication type:
- Article
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 2, p. 211, doi. 10.3892/ijo.2021.5167
- By:
- Publication type:
- Article
Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.748657
- By:
- Publication type:
- Article